Solid Biosciences (SLDB) Free Cash Flow Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.71% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 31.42% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -18.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.36% |
| Dec 31, 2025 | -15.26% |
| Sep 30, 2025 | -18.43% |
| Jun 30, 2025 | -32.64% |
| Mar 31, 2025 | -5.16% |
| Dec 31, 2024 | -13.30% |
| Sep 30, 2024 | -7.69% |
| Jun 30, 2024 | -7.63% |
| Mar 31, 2024 | -5.79% |
| Dec 31, 2023 | -171.05% |
| Sep 30, 2023 | -4.31% |
| Jun 30, 2023 | -25.31% |
| Mar 31, 2023 | 0.95% |
| Dec 31, 2022 | -16.70% |
| Sep 30, 2022 | -0.26% |
| Jun 30, 2022 | 16.09% |
| Mar 31, 2022 | 0.51% |
| Dec 31, 2021 | 2.32% |
| Sep 30, 2021 | -17.92% |
| Jun 30, 2021 | 4.34% |
| Mar 31, 2021 | -5.60% |
| Dec 31, 2020 | 28.09% |
| Sep 30, 2020 | -12.22% |
| Jun 30, 2020 | -11.59% |
| Mar 31, 2020 | -42.14% |